scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023147360 |
P356 | DOI | 10.1186/CC10237 |
P932 | PMC publication ID | 3218990 |
P698 | PubMed publication ID | 21639957 |
P5875 | ResearchGate publication ID | 51190270 |
P50 | author | Pieter Roel Tuinman | Q42314955 |
Nicole P Juffermans | Q88062370 | ||
P2860 | cites work | The platelet as an immune cell-CD40 ligand and transfusion immunomodulation | Q33937074 |
Association between serum soluble CD40 ligand levels and mortality in patients with severe sepsis. | Q35559467 | ||
Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury | Q35849153 | ||
Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature | Q37234940 | ||
Platelet-derived CD40L (CD154) mediates neutrophil upregulation of Mac-1 and recruitment in septic lung injury | Q45056628 | ||
Transfusion-related risk of secondary bacterial infections in sepsis patients: a retrospective cohort study. | Q50550381 | ||
P433 | issue | 3 | |
P921 | main subject | sepsis | Q183134 |
P304 | page(s) | 429; author reply 429 | |
P577 | publication date | 2011-05-31 | |
P1433 | published in | Critical Care | Q5186602 |
P1476 | title | Soluble CD40 ligand, a mediator of sepsis or of transfusion-related adverse effects? | |
P478 | volume | 15 |